Clik here to view.
面对事实：卒中是可以治疗的
印度海得拉巴 (美国商业资讯) — 世界上每2秒钟就有人发生卒中。卒中是全球第一致残原因和和第二死因。 正确的卒中医护能够挽救生命，但全球并非每个人都能获得平等的挽救生命的治疗。 今天是世界卒中日（2016年10月29日星期六），世界卒中组织(WSO)呼吁全球行动起来减少卒中治疗中的不平等，以帮助挽救数百万生命。 在印度海得拉巴召开的世界卒中大会上，WSO主席Stephen...
View ArticleClik here to view.
事実を直視する：脳卒中は治療可能
印ハイデラバード （ビジネスワイヤ） — 世界中では2秒に1人のペースで誰かが脳卒中を起こしています。脳卒中は世界で障害の主因の第1位、死亡の主因の第2位を占めています。 脳卒中の正しい治療は命を救うことができますが、世界では命を救う治療へのアクセスは誰もが同じというわけではありません。...
View ArticleClik here to view.
武田公布2016财年上半年业绩并提高全年利润指引
日本大阪 (美国商业资讯)–武田药品工业株式会社(TOKYO:4502)： 强劲的上半年业绩得益于增长引擎 得益于武田增长引擎（胃肠药、肿瘤药、CNS和新兴市场）+15.3%的增长，基础营收增长+7.4%。 由于不利的汇率影响（-8.6个百分点）和剥离影响（-4.7个百分点），报告的营收下降5.9%。...
View ArticleClik here to view.
AtriCure Announces Approval for the cryoICE™ Platform in Japan
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval...
View ArticleClik here to view.
エイトリキュアがcryoICE™プラットフォームの日本での承認を発表
米オハイオ州メーソン （ビジネスワイヤ） — 心房細動（Afib）治療と左心耳（LAA）管理における一流イノベーター企業のエイトリキュア（Nasdaq: ATRC）は本日、cryoICE™プラットフォームおよびCRYO2冷凍アブレーションプローブの承認を厚生労働省より取得したと発表しました。承認により、これらの製品が日本市場で初めて提供可能になります。...
View ArticleClik here to view.
Custom PCR Master Mixes Ship in 10 Days with New Promega cGMP PCR Kit for...
MADISON, Wis. Now available, the Promega PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix manufactured under cGMP for research or clinical use. The user’s...
View ArticleClik here to view.
Takeda to Present Broad Range of Clinical Data During 58th American Society...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 16 company-sponsored abstracts at the 58th American Society of...
View ArticleClik here to view.
Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient...
AMSTERDAM & IRVINE, Calif. Royal Philips (NYSE: PHG; AEX: PHIA) and Masimo Corporation (NASDAQ: MASI) today announced a wide-ranging, multi-year business partnership involving both companies’...
View ArticleClik here to view.
Elanix Biotechnologies AG Strategic Partner, Transwell Biotechnology Ltd.,...
NYON, Switzerland & POTSDAM, Germany Elanix Biotechnologies AG (“Elanix” – FSE: ELN), a developer of tissue regeneration and cosmetic products, announces that their licensed partner Transwell...
View ArticleClik here to view.
飞利浦与Masimo签署患者监护和选定治疗解决方案的多年业务伙伴关系协议
阿姆斯特丹和加州尔湾 (美国商业资讯) — 皇家飞利浦(NYSE: PHG; AEX: PHIA)和Masimo公司(NASDAQ:...
View ArticleClik here to view.
Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical...
BOTHELL, Wash. & CAMBRIDGE, Mass. Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced completion of patient enrollment in the ECHELON-2...
View ArticleClik here to view.
フィリップスとマシモが患者モニタリングと一部の治療ソリューションで複数年の事業提携契約を締結
アムステルダム & 米カリフォルニア州アーバイン （ビジネスワイヤ） — ロイヤル フィリップス（NYSE: PHG、AEX: PHIA）とマシモコーポレーション（NASDAQ:...
View ArticleClik here to view.
Sosei Subsidiaries Heptares and Jitsubo to Develop Novel GPCR-Targeting...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565) announces that its subsidiaries, Heptares Therapeutics (“Heptares”) and Jitsubo Co., Ltd. (“Jitsubo”), have entered into a...
View ArticleClik here to view.
Cell Culture Company (C3) Deal Targets Pancreatic Cancer
MINNEAPOLIS Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, announced today it has entered into an agreement with a China-based joint venture to produce a clinical-grade...
View ArticleClik here to view.
UC San Francisco Professor Receives Honorary Doctorate from NCKU
TAINAN, Taiwan Dr. Zena Werb, professor and vice chair of the Department of Anatomy at University of California (UC), San Francisco, USA, received an honorary doctoral degree from National Cheng...
View ArticleClik here to view.
Cardiovascular Systems, Inc. Signs Distribution Agreement with Medikit Co.,...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) has signed an exclusive distribution agreement with Medikit Co., Ltd. to sell its Diamondback 360® Coronary and Peripheral Orbital...
View ArticleClik here to view.
[KOREA TL Plastic Surgery]‘Nothing Can Replace SMAS Face Lifting!’
SEOUL, South Korea If you look older than your age due to drooping skin and deep wrinkles, your best option would be a superficial muscular aponeurotic system-SMAS face lifting. This Smart News...
View ArticleClik here to view.
Clik here to view.
HeartFlow FFRct Analysis Receives Regulatory Approval in Japan
REDWOOD CITY, Calif. HeartFlow, Inc. has announced the approval of its HeartFlow® FFRct Analysis by the Japanese Ministry of Health, Labour and Welfare (MHLW). The HeartFlow FFRct Analysis is the...
View ArticleClik here to view.
新的里程碑研究显示，成人糖尿病患者存在不必要的失明风险
英格兰纽伯里 (美国商业资讯) — 对失明的恐惧是对糖尿病其他常见并发症（包括心血管疾病和卒中）恐惧的两倍之多，尽管如此，在受访的糖尿病患者中，有四分之一的病人并没有与他们的医疗保健专业人员讨论眼科并发症，许多人在视力问题已发生时才去就诊。1 今天发布的DR...
View Article